Yokota H, Tamura S, Furuya H, Kimura S, Watanabe M, Kanazawa I, Kondo I, Gonzalez F J
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Pharmacogenetics. 1993 Oct;3(5):256-63. doi: 10.1097/00008571-199310000-00005.
A group of Japanese subjects were phenotyped for CYP2D6 activity by administration of sparteine and determination of urine metabolic ratios (MR). The CYP2D6 alleles from two subjects having a high MR, characteristic of slower rates of sparteine metabolism, were cloned in lambda EMBL3 and subjected to sequence analysis. One individual possessed a CYP2D6B allele, typically found in Caucasians, that is inactive due to an altered 3' splice recognition site and other potentially disruptive mutations. The second allele from this individual was identical to the wild type normal Caucasian CYP2D6 allele except for C188T and G4268C base differences in exons 1 and 9, respectively, that result in P34S and S486T amino acid substitutions. This allele was designated CYP2D6J. The second individual possessed two CYP2D6J alleles. PCR assays were performed to detect this allele and other alleles from a group of subjects exhibiting low rates of sparteine metabolism, i.e. with MRs > 1.5. Eleven CYP2D6J alleles were detected in 14 subjects exhibiting low rates of metabolism and including four individuals who were homozygous for this variant and had very low rates of sparteine metabolism (MRs > 2.5). In contrast, only two CYP2D6J alleles were found in 14 subjects having MRs of < 1.0. These data suggest that CYP2D6J encodes an enzyme having lower rates of sparteine metabolism.
通过给予司巴丁并测定尿液代谢率(MR),对一组日本受试者的CYP2D6活性进行了表型分析。从两名代谢率高(司巴丁代谢速率较慢的特征)的受试者中克隆出CYP2D6等位基因,克隆载体为λEMBL3,并进行序列分析。其中一名个体拥有一个CYP2D6B等位基因,该等位基因通常在高加索人中发现,由于3'剪接识别位点改变和其他潜在的破坏性突变而无活性。该个体的第二个等位基因与野生型正常高加索人CYP2D6等位基因相同,只是在外显子1和9中分别存在C188T和G4268C碱基差异,导致P34S和S486T氨基酸替换。这个等位基因被命名为CYP2D6J。第二名个体拥有两个CYP2D6J等位基因。进行PCR检测以从一组司巴丁代谢率低(即MR>1.5)的受试者中检测该等位基因和其他等位基因。在14名代谢率低的受试者中检测到11个CYP2D6J等位基因,其中包括4名该变体纯合子且司巴丁代谢率极低(MR>2.5)的个体。相比之下,在14名MR<1.0的受试者中仅发现两个CYP2D6J等位基因。这些数据表明,CYP2D6J编码一种司巴丁代谢率较低的酶。